Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2026-05-22 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 95% confidence The document is an Italian regulated press release detailing the weekly purchase of the company’s own shares under an authorized buyback program, including quantities, prices, and percentages of share capital. This clearly matches the "Transaction in Own Shares" category (code POS).
2026-05-22 Italian
Assemblea degli azionisti approva il Bilancio 2025
Notice of Dividend Amount Classification · 85% confidence The document is a press release summarizing the resolutions of the Annual General Meeting, most notably the approval of the 2025 financial statements and the declaration of a dividend of €0.20 per share with ex-dividend date, record date and payment date specified. This aligns with the “Notice of Dividend Amount” category (DIV), which covers announcements of dividend amounts and related payment details. It is not the full annual report, nor an AGM presentation, nor simply a report publication notice; rather it is specifically communicating dividend information to shareholders.
2026-05-20 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 93% confidence The document is a regulated press release (“Comunicato Stampa”) reporting the weekly purchases of the company’s own shares, including daily quantities, prices, total amounts, and the resulting holdings. This clearly matches the definition of a “Transaction in Own Shares” (share buybacks) rather than an earnings report, dividend notice, or other category.
2026-05-15 Italian
Cda esamina i Ricavi consolidati al 31.03.2026
Earnings Release Classification · 85% confidence The document is a regulatory press release announcing the Board’s review of consolidated revenues for the quarter ended 31 March 2026, with high‐level Q1 revenue figures and commentary. It does not include full interim financial statements, but provides key highlights of quarterly results, consistent with an Earnings Release. Q1 2026
2026-05-11 Italian
Acquisto azioni proprie
Regulatory Filings
2026-05-08 Italian
Convocazione Assemblea azionisti e messa a disposizione documenti
Regulatory Filings
2026-05-05 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.